335 related articles for article (PubMed ID: 15836467)
1. Stearoyl-CoA desaturase as a new drug target for obesity treatment.
Dobrzyn A; Ntambi JM
Obes Rev; 2005 May; 6(2):169-74. PubMed ID: 15836467
[TBL] [Abstract][Full Text] [Related]
2. Stearoyl-CoA desaturase--a new player in skeletal muscle metabolism regulation.
Dobrzyń A; Dobrzyń P
J Physiol Pharmacol; 2006 Nov; 57 Suppl 10():31-42. PubMed ID: 17242489
[TBL] [Abstract][Full Text] [Related]
3. Stearoyl-CoA desaturase-1 deficiency reduces ceramide synthesis by downregulating serine palmitoyltransferase and increasing beta-oxidation in skeletal muscle.
Dobrzyn A; Dobrzyn P; Lee SH; Miyazaki M; Cohen P; Asilmaz E; Hardie DG; Friedman JM; Ntambi JM
Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E599-607. PubMed ID: 15562249
[TBL] [Abstract][Full Text] [Related]
4. The role of stearoyl-CoA desaturase in body weight regulation.
Dobrzyn A; Ntambi JM
Trends Cardiovasc Med; 2004 Feb; 14(2):77-81. PubMed ID: 15030794
[TBL] [Abstract][Full Text] [Related]
5. The role of stearoyl-CoA desaturase in the control of metabolism.
Dobrzyn A; Ntambi JM
Prostaglandins Leukot Essent Fatty Acids; 2005 Jul; 73(1):35-41. PubMed ID: 15941655
[TBL] [Abstract][Full Text] [Related]
6. Hepatic stearoyl-CoA desaturase-1 deficiency protects mice from carbohydrate-induced adiposity and hepatic steatosis.
Miyazaki M; Flowers MT; Sampath H; Chu K; Otzelberger C; Liu X; Ntambi JM
Cell Metab; 2007 Dec; 6(6):484-96. PubMed ID: 18054317
[TBL] [Abstract][Full Text] [Related]
7. Development of a high-throughput screening assay for stearoyl-CoA desaturase using rat liver microsomes, deuterium labeled stearoyl-CoA and mass spectrometry.
Soulard P; McLaughlin M; Stevens J; Connolly B; Coli R; Wang L; Moore J; Kuo MS; LaMarr WA; Ozbal CC; Bhat BG
Anal Chim Acta; 2008 Oct; 627(1):105-11. PubMed ID: 18790133
[TBL] [Abstract][Full Text] [Related]
8. Loss of stearoyl-CoA desaturase 1 inhibits fatty acid oxidation and increases glucose utilization in the heart.
Dobrzyn P; Sampath H; Dobrzyn A; Miyazaki M; Ntambi JM
Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E357-64. PubMed ID: 18042664
[TBL] [Abstract][Full Text] [Related]
9. Cideb regulates diet-induced obesity, liver steatosis, and insulin sensitivity by controlling lipogenesis and fatty acid oxidation.
Li JZ; Ye J; Xue B; Qi J; Zhang J; Zhou Z; Li Q; Wen Z; Li P
Diabetes; 2007 Oct; 56(10):2523-32. PubMed ID: 17646209
[TBL] [Abstract][Full Text] [Related]
10. Stearoyl-coenzyme A desaturase 1, sterol regulatory element binding protein-1c and peroxisome proliferator-activated receptor-alpha: independent and interactive roles in the regulation of lipid metabolism.
Sampath H; Ntambi JM
Curr Opin Clin Nutr Metab Care; 2006 Mar; 9(2):84-8. PubMed ID: 16477170
[TBL] [Abstract][Full Text] [Related]
11. Stearoyl-CoA desaturase-1 and the metabolic syndrome.
Cohen P; Ntambi JM; Friedman JM
Curr Drug Targets Immune Endocr Metabol Disord; 2003 Dec; 3(4):271-80. PubMed ID: 14683458
[TBL] [Abstract][Full Text] [Related]
12. Leptin suppresses stearoyl-CoA desaturase 1 by mechanisms independent of insulin and sterol regulatory element-binding protein-1c.
Biddinger SB; Miyazaki M; Boucher J; Ntambi JM; Kahn CR
Diabetes; 2006 Jul; 55(7):2032-41. PubMed ID: 16804073
[TBL] [Abstract][Full Text] [Related]
13. [Stearoyl-CoA desaturase in the control of metabolic homeostasis].
Dobrzyń P
Postepy Biochem; 2012; 58(2):166-74. PubMed ID: 23214140
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of stearoyl-CoA desaturase1 activates AMPK and exhibits beneficial lipid metabolic effects in vitro.
Kim E; Lee JH; Ntambi JM; Hyun CK
Eur J Pharmacol; 2011 Dec; 672(1-3):38-44. PubMed ID: 21970804
[TBL] [Abstract][Full Text] [Related]
15. Prevention of obesity in mice by antisense oligonucleotide inhibitors of stearoyl-CoA desaturase-1.
Jiang G; Li Z; Liu F; Ellsworth K; Dallas-Yang Q; Wu M; Ronan J; Esau C; Murphy C; Szalkowski D; Bergeron R; Doebber T; Zhang BB
J Clin Invest; 2005 Apr; 115(4):1030-8. PubMed ID: 15761499
[TBL] [Abstract][Full Text] [Related]
16. Diet-induced changes in stearoyl-CoA desaturase 1 expression in obesity-prone and -resistant mice.
Hu CC; Qing K; Chen Y
Obes Res; 2004 Aug; 12(8):1264-70. PubMed ID: 15340109
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological inhibition of stearoyl-CoA desaturase 1 improves insulin sensitivity in insulin-resistant rat models.
Issandou M; Bouillot A; Brusq JM; Forest MC; Grillot D; Guillard R; Martin S; Michiels C; Sulpice T; Daugan A
Eur J Pharmacol; 2009 Sep; 618(1-3):28-36. PubMed ID: 19616540
[TBL] [Abstract][Full Text] [Related]
18. Discovery of potent liver-selective stearoyl-CoA desaturase-1 (SCD1) inhibitors, thiazole-4-acetic acid derivatives, for the treatment of diabetes, hepatic steatosis, and obesity.
Iida T; Ubukata M; Mitani I; Nakagawa Y; Maeda K; Imai H; Ogoshi Y; Hotta T; Sakata S; Sano R; Morinaga H; Negoro T; Oshida S; Tanaka M; Inaba T
Eur J Med Chem; 2018 Oct; 158():832-852. PubMed ID: 30248655
[TBL] [Abstract][Full Text] [Related]
19. Hepatic stearoyl CoA desaturase 1 deficiency increases glucose uptake in adipose tissue partially through the PGC-1α-FGF21 axis in mice.
Aljohani A; Khan MI; Bonneville A; Guo C; Jeffery J; O'Neill L; Syed DN; Lewis SA; Burhans M; Mukhtar H; Ntambi JM
J Biol Chem; 2019 Dec; 294(51):19475-19485. PubMed ID: 31690632
[TBL] [Abstract][Full Text] [Related]
20. Role of hepatic desaturases in obesity-related metabolic disorders.
Bjermo H; Risérus U
Curr Opin Clin Nutr Metab Care; 2010 Nov; 13(6):703-8. PubMed ID: 20823776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]